Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Genmab Rises After FDA Grants Breakthrough Status to Cancer Drug
Genmab Rises After FDA Grants Breakthrough Status to Cancer Drug
Genmab Rises After FDA Grants Breakthrough Status to Cancer Drug
Submitted by
admin
on May 2, 2013 - 10:31am
Source:
Bloomberg
News Tags:
Genmab
FDA
JNJ
daratumumab
Multiple Myeloma
Headline:
Genmab Rises After FDA Grants Breakthrough Status to Cancer Drug
Do Not Allow Advertisers to Use My Personal information
